share_log

京新药业:随着医药改革的深化医药经营模式正在升级阶段

Stock Star ·  Mar 13 11:42

证券之星消息,京新药业(002020)03月13日在投资者关系平台上答复投资者关心的问题。

投资者提问:公司拿全体股民的真金白银7亿回购公司股份,说基予公司的良好发展前景,那请问公司吕董今年今司的增长前景到底如何?中短期发展规划和目标是什么?

京新药业回复:您好!随着医药改革的深化,医药经营模式正在升级阶段,医药企业面临着机遇和挑战,公司会发挥经营韧性,坚定创新转型,实现业务健康有序发展。谢谢!

以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 264

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.